Biomedical Engineering Reference
In-Depth Information
Ter-Avetisyan G, Tünnemann G, Nowak D, Nitschke M, Herrmann A, Drab M, Cardoso MC
(2009) Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem
284:3370-3378.
Terrone D, Sang SL, Roudaia L, Silvius JR (2003) Penetratin and related cell-penetrating cationic
peptides can translocate across lipid bilayers in the presence of a transbilayer potential.
Biochemistry 42:13787-13799.
Thoren PE, Persson D, Karlsson M, Norden B (2000) The antennapedia peptide penetratin trans-
locates across lipid bilayers — the first direct observation. FEBS Lett 482:265-268.
Thoren PE, Persson D, Lincoln P, Norden B (2005) Membrane destabilizing properties of cell-
penetrating peptides. Biophys. Chem. 114:169-179.
Tiriveedhi V, Butko P (2007) A fluorescence spectroscopy study on the interactions of the TAT-PTD
peptide with model lipid membranes. Biochemistry 46: 3888-3895.
Verdurmen WPR, Thanos M, Ruttekolk IR, Gulbins E, Brock R (2010) Cationic cell-penetrating
peptides induce ceramide formation via acid sphingomyelinase: Implications for uptake. J
Control Release 147:171-179.
Vives E, Brodin P, Lebleu BA (1997) truncated HIV-1 Tat protein basic domain rapidly translo-
cates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem
272:16010-16017.
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape
of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310-315.
Walter C, Ott I, Gust R, Neundorf I (2009) Specific Labeling With Potent Radiolabels Alters the
Uptake of Cell-Penetrating Peptides. Biopolymers 92:445-451.
Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2001) The
design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid
molecular transporters. Proc Nat Acad Sci 97:13003-13008.
Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH (2008) The design of guanidinium-rich
transporters and their internalization mechanisms. Adv Drug Deliv Rev 60:452-72.
Weeks BS, Lieberman DM, Johnson B, Roque E, Green M, Loewenstein P, Oldfield EH, Kleinman
HK (1995) Neurotoxicity of the human-immunodeficiency-virus type-1 TAT transactivator to
PC12 cells requires the Tat amino-acid-49-58 basic domain. J Neurosci Res 42:34-40.
Wieprecht T, Beyermann M, Seelig J (2002) Thermodynamics of the coil alpha-helix transition of
amphipathic peptides in a membrane environment: the role of vesicle curvature. Biophys Chem
96:191-201.
Ye J, Fox SA, Cudic M, Rezler EM, Lauer JL, Fields GB, Terentis AC (2010) Determination of
penetratin secondary structure in live cells with Raman microscopy. J Am Chem Soc
132:980-988.
Yesylevskyy S, Marrink SJ, Mark AE (2009) Alternative mechanisms for the interaction of the cell-
penetrating peptides penetratin and the TAT peptide with lipid bilayers. Biophys J. 97:40-9.
Ziegler A, Seelig J (2004) Interaction of the protein transduction domain of HIV-1 TAT with heparan
sulfate: binding mechanism and thermodynamic parameters. Biophys J. 86:254-63.
Zimm BH, Le Bret M (1983) Counter-ion condensation and system dimensionality. J Biomol
Struct Dyn 1:461-471.
Search WWH ::




Custom Search